These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34931285)

  • 1. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
    Sakamoto A; Sugano K
    Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
    Okamoto N; Higashino M; Yamamoto H; Sugano K
    Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
    Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
    Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
    Bapat P; Paul S; Thakral NK; Tseng YC; Taylor LS
    Mol Pharm; 2023 Nov; 20(11):5714-5727. PubMed ID: 37751517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model.
    Jede C; Wagner C; Kubas H; Weigandt M; Weber C; Lecomte M; Badolo L; Koziolek M; Weitschies W
    Mol Pharm; 2019 Sep; 16(9):3938-3947. PubMed ID: 31335153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.
    Sudaki H; Fujimoto K; Wada K; Sugano K
    Drug Metab Pharmacokinet; 2023 Aug; 51():100519. PubMed ID: 37393739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
    Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
    Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot-melt extruded hydroxypropyl methylcellulose acetate succinate based amorphous solid dispersions: Impact of polymeric combinations on supersaturation kinetics and dissolution performance.
    Butreddy A; Sarabu S; Almutairi M; Ajjarapu S; Kolimi P; Bandari S; Repka MA
    Int J Pharm; 2022 Mar; 615():121471. PubMed ID: 35041915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
    Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
    AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
    Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
    Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer.
    Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W
    Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer.
    Yamamoto H; Sugano K
    Mol Pharm; 2024 Jun; 21(6):2854-2864. PubMed ID: 38718215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring biorelevant conditions and release profiles of ritonavir from HPMCAS-based amorphous solid dispersions.
    Bapat P; Schwabe R; Paul S; Tseng YC; Bergman C; Taylor LS
    J Pharm Sci; 2025 Jan; 114(1):185-198. PubMed ID: 39186978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
    McNamara DP; Whitney KM; Goss SL
    Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
    Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
    Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is bicarbonate buffer suitable as a dissolution medium?
    Boni JE; Brickl RS; Dressman J
    J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets.
    Ikuta S; Nakagawa H; Kai T; Sugano K
    Eur J Pharm Sci; 2023 Jan; 180():106326. PubMed ID: 36347443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.